Literature DB >> 32510613

Genetic screens reveal CCDC115 as a modulator of erythroid iron and heme trafficking.

Amin Sobh1,2, Alex Loguinov2, Jie Zhou2,3, Supak Jenkitkasemwong3, Rola Zeidan2, Nader El Ahmadie2, Abderrahmane Tagmount2, Mitchell Knutson3, Paula G Fraenkel4,5,6, Christopher D Vulpe2.   

Abstract

Transferrin-bound iron (TBI), the physiological circulating iron form, is acquired by cells through the transferrin receptor (TfR1) by endocytosis. In erythroid cells, most of the acquired iron is incorporated into heme in the mitochondria. Cellular trafficking of heme is indispensable for erythropoiesis and many other essential biological processes. Comprehensive elucidation of molecular pathways governing and regulating cellular iron acquisition and heme trafficking is required to better understand physiological and pathological processes affecting erythropoiesis. Here, we report the first genome-wide clustered regularly interspaced short palindromic repeats (CRISPR) screens in human erythroid cells to identify determinants of iron and heme uptake, as well as heme-mediated erythroid differentiation. We identified several candidate modulators of TBI acquisition including TfR1, indicating that our approach effectively revealed players mechanistically relevant to the process. Interestingly, components of the endocytic pathway were also revealed as potential determinants of transferrin acquisition. We deciphered a role for the vacuolar-type H+ - ATPase (V- ATPase) assembly factor coiled-coil domain containing 115 (CCDC115) in TBI uptake and validated this role in CCDC115 deficient K562 cells. Our screen in hemin-treated cells revealed perturbations leading to cellular adaptation to heme, including those corresponding to trafficking mechanisms and transcription factors potentiating erythroid differentiation. Pathway analysis indicated that endocytosis and vesicle acidification are key processes for heme trafficking in erythroid precursors. Furthermore, we provided evidence that CCDC115, which we identified as required for TBI uptake, is also involved in cellular heme distribution. This work demonstrates a previously unappreciated common intersection in trafficking of transferrin iron and heme in the endocytic pathway of erythroid cells.
© 2020 Wiley Periodicals LLC.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32510613     DOI: 10.1002/ajh.25899

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  5 in total

Review 1.  Iron homeostasis and organismal aging.

Authors:  Rola S Zeidan; Sung Min Han; Christiaan Leeuwenburgh; Rui Xiao
Journal:  Ageing Res Rev       Date:  2021-11-09       Impact factor: 10.895

2.  CCDC65, a Gene Knockout that leads to Early Death of Mice, acts as a potentially Novel Tumor Suppressor in Lung Adenocarcinoma.

Authors:  Ziyan Zhang; Ping Xu; Zhe Hu; Zhaojian Fu; Tongyuan Deng; Xiaojie Deng; Lanzhu Peng; Yingying Xie; Lingzhi Long; Dayong Zheng; Peng Shen; Mengmin Zhang; Bin Gong; Zhibo Zhu; Junhao Lin; Rui Chen; Zhen Liu; Huilin Yang; Rong Li; Weiyi Fang
Journal:  Int J Biol Sci       Date:  2022-06-27       Impact factor: 10.750

Review 3.  Molecular Mechanisms of Iron and Heme Metabolism.

Authors:  Sohini Dutt; Iqbal Hamza; Thomas Benedict Bartnikas
Journal:  Annu Rev Nutr       Date:  2022-05-04       Impact factor: 9.323

Review 4.  Iron Metabolism in Aging and Age-Related Diseases.

Authors:  Yao Tian; Yuanliangzi Tian; Zhixiao Yuan; Yutian Zeng; Shuai Wang; Xiaolan Fan; Deying Yang; Mingyao Yang
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

Review 5.  Iron and manganese transport in mammalian systems.

Authors:  Qingli Liu; Saiid Barker; Mitchell D Knutson
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-10-19       Impact factor: 4.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.